256 related articles for article (PubMed ID: 29506270)
1. Development and Validation of a Novel RNA Sequencing-Based Prognostic Score for Acute Myeloid Leukemia.
Wang M; Lindberg J; Klevebring D; Nilsson C; Lehmann S; Grönberg H; Rantalainen M
J Natl Cancer Inst; 2018 Oct; 110(10):1094-1101. PubMed ID: 29506270
[TBL] [Abstract][Full Text] [Related]
2. Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.
Wang M; Lindberg J; Klevebring D; Nilsson C; Mer AS; Rantalainen M; Lehmann S; Grönberg H
Leukemia; 2017 Oct; 31(10):2029-2036. PubMed ID: 28167833
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients.
Tsai CH; Yao CY; Tien FM; Tang JL; Kuo YY; Chiu YC; Lin CC; Tseng MH; Peng YL; Liu MC; Liu CW; Yao M; Lin LI; Chou WC; Chen CY; Hou HA; Tien HF
EBioMedicine; 2019 Feb; 40():240-250. PubMed ID: 30662003
[TBL] [Abstract][Full Text] [Related]
4. Construction of prognostic risk prediction model based on high-throughput sequencing expression profile data in childhood acute myeloid leukemia.
Niu P; Yao B; Wei L; Zhu H; Fang C; Zhao Y
Blood Cells Mol Dis; 2019 Jul; 77():43-50. PubMed ID: 30954792
[TBL] [Abstract][Full Text] [Related]
5. LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia.
Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
BMC Cancer; 2020 Sep; 20(1):841. PubMed ID: 32883226
[TBL] [Abstract][Full Text] [Related]
6. A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients.
Wang F; Tian X; Zhou J; Wang G; Yu W; Li Z; Fan Z; Zhang W; Liang A
Mol Med Rep; 2018 Aug; 18(2):1473-1484. PubMed ID: 29901168
[TBL] [Abstract][Full Text] [Related]
7. Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study.
Li Z; Herold T; He C; Valk PJ; Chen P; Jurinovic V; Mansmann U; Radmacher MD; Maharry KS; Sun M; Yang X; Huang H; Jiang X; Sauerland MC; Büchner T; Hiddemann W; Elkahloun A; Neilly MB; Zhang Y; Larson RA; Le Beau MM; Caligiuri MA; Döhner K; Bullinger L; Liu PP; Delwel R; Marcucci G; Lowenberg B; Bloomfield CD; Rowley JD; Bohlander SK; Chen J
J Clin Oncol; 2013 Mar; 31(9):1172-81. PubMed ID: 23382473
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a 10-gene prognostic signature for acute myeloid leukaemia.
Yang Z; Shang J; Li N; Zhang L; Tang T; Tian G; Chen X
J Cell Mol Med; 2020 Apr; 24(8):4510-4523. PubMed ID: 32150667
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia.
Park S; Kim YJ; Huh HJ; Chung HS; Lee M; Park YM; Mun YC; Seong CM; Huh J
Hematology; 2021 Dec; 26(1):904-913. PubMed ID: 34789078
[TBL] [Abstract][Full Text] [Related]
10. A new prognostic risk model for acute myeloid leukemia patients based on telomere-related genes.
Zhang F; Du H; Hu C; Song Y
Leuk Res; 2023 Dec; 135():107404. PubMed ID: 37844405
[TBL] [Abstract][Full Text] [Related]
11. NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.
Chretien AS; Fauriat C; Orlanducci F; Rey J; Borg GB; Gautherot E; Granjeaud S; Demerle C; Hamel JF; Cerwenka A; von Strandmann EP; Ifrah N; Lacombe C; Cornillet-Lefebvre P; Delaunay J; Toubert A; Arnoulet C; Vey N; Olive D
Oncotarget; 2017 Jul; 8(30):49548-49563. PubMed ID: 28548938
[TBL] [Abstract][Full Text] [Related]
12. A three-gene signature and clinical outcome in pediatric acute myeloid leukemia.
Cai Z; Wu Y; Zhang F; Wu H
Clin Transl Oncol; 2021 Apr; 23(4):866-873. PubMed ID: 32862280
[TBL] [Abstract][Full Text] [Related]
13. Systematic Analysis of Autophagy-Related Signature Uncovers Prognostic Predictor for Acute Myeloid Leukemia.
Chen XX; Li ZP; Zhu JH; Xia HT; Zhou H
DNA Cell Biol; 2020 Sep; 39(9):1595-1605. PubMed ID: 32783661
[TBL] [Abstract][Full Text] [Related]
14. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.
Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L
Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705
[TBL] [Abstract][Full Text] [Related]
15. High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia.
Yu X; Chen C; Hu Y; Li K; Zhang Y; Chen Z; Nie D; Gao R; Huang Y; Zhong M; Wang C; Wang S; Zeng Y; Li Y; Zeng C
Cancer Med; 2023 Apr; 12(7):9055-9067. PubMed ID: 36708053
[TBL] [Abstract][Full Text] [Related]
16. Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia.
Jin P; Tan Y; Zhang W; Li J; Wang K
Neoplasia; 2020 Sep; 22(9):447-457. PubMed ID: 32653835
[TBL] [Abstract][Full Text] [Related]
17. Determining breast cancer histological grade from RNA-sequencing data.
Wang M; Klevebring D; Lindberg J; Czene K; Grönberg H; Rantalainen M
Breast Cancer Res; 2016 May; 18(1):48. PubMed ID: 27165105
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia.
Shi M; Xu G
BMC Med Genomics; 2019 Jun; 12(1):90. PubMed ID: 31242922
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide identification of FHL1 as a powerful prognostic candidate and potential therapeutic target in acute myeloid leukaemia.
Fu Y; Xu M; Cui Z; Yang Z; Zhang Z; Yin X; Huang X; Zhou M; Wang X; Chen C
EBioMedicine; 2020 Feb; 52():102664. PubMed ID: 32062360
[TBL] [Abstract][Full Text] [Related]
20. A three-gene expression-based risk score can refine the European LeukemiaNet AML classification.
Wilop S; Chou WC; Jost E; Crysandt M; Panse J; Chuang MK; Brümmendorf TH; Wagner W; Tien HF; Kharabi Masouleh B
J Hematol Oncol; 2016 Sep; 9(1):78. PubMed ID: 27585840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]